Renin

BBX Capital, Inc. Reports Financial Results For the Fourth Quarter and Full Year of 2023

Retrieved on: 
Friday, March 15, 2024
Other Consumer, Food, Beverage, Home Goods, Retail, Urban Planning, Family, Finance, Online Retail, Interior Design, Consumer, Luxury, Other Construction & Property, Professional Services, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Vacation, Lodging, Travel, Tax, Renin, BVH, Sale, BBX, Investment, OTCQX, PINK, Treasury, Balance sheet, Total

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the fourth quarter and year ended December 31, 2023.
  • Selected highlights of BBX Capital’s consolidated financial results include:
    Total consolidated revenues of $96.1 million vs. $107.6 million
    Net loss attributable to shareholders of $(12.9) million vs. net income attributable to shareholders of $15.4 million
    Diluted loss per share of $(0.88) vs. diluted earnings per share of $0.99
    Year Ended December 31, 2023 Compared to the Year Ended December 31, 2022
    Total consolidated revenues of $401.3 million vs. $342.0 million
    Loss before income taxes of $(21.7) million vs. income before income taxes of $42.8 million
    Net loss attributable to shareholders of $(20.8) million vs. income attributable to shareholders of $28.0 million
    Balance Sheet as of December 31, 2023
    Securities available for sale of $44.6 million (primarily U.S. Treasury and federal agency securities with maturities of less than one year)
    Note receivable from Bluegreen Vacations Holding Corporation (NYSE: BVH) of $35.0 million (1)
    The outstanding balance of the note receivable was prepaid in full in January 2024.
  • Fully diluted book value per share is shareholders’ equity divided by the number of BBX Capital’s Class A and Class B common shares and unvested restricted stock awards outstanding on December 31, 2023.
  • For more complete and detailed information regarding BBX Capital and its financial results, business, operations, investments, and risks, including the results of BBX Capital Real Estate, BBX Sweet Holdings, and Renin, please see BBX Capital’s Annual Report on Form 10-K for the year ended December 31, 2023, which is available on the SEC's website, https://www.sec.gov , and on BBX Capital’s website, www.BBXCapital.com .

BBX Capital, Inc. Reports Financial Results For the Third Quarter of 2023

Retrieved on: 
Wednesday, November 8, 2023
Food, Beverage, Home Goods, Retail, Children, Urban Planning, Finance, Online Retail, Interior Design, Luxury, Consumer, Professional Services, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Vacation, Other Travel, Lodging, Travel, Sale, Toronto-Dominion Bank, Renin, NYSE, Tax, Miramar, OTCQX, Environment, Growth, Balance sheet, BBX Capital Corporation, TD, BBX, Investment, BVH, PINK, Renting, Security (finance), Video game, Renewable energy, Warehouse

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the third quarter of 2023.

Key Points: 
  • BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the third quarter of 2023.
  • The following selected information relates to the financial results of the Company’s principal holdings: BBX Capital Real Estate, BBX Sweet Holdings, and Renin.
  • In connection with the transition, BBX Sweet Holdings acquired his noncontrolling interest in IT’SUGAR, and as a result, IT'SUGAR became a wholly-owned subsidiary of BBX Sweet Holdings during the three months ended September 30, 2023.
  • As of September 30, 2023, Renin was current on the payment terms under its TD Bank credit facility.

BBX Capital, Inc. Reports Financial Results For the Second Quarter of 2023

Retrieved on: 
Wednesday, August 9, 2023
Professional Services, Finance, Altman, BBX, TD, Olympia, Greece, BBX Capital Corporation, Tax, BVH, Toronto-Dominion Bank, Balance sheet, Second, Sale, Investment, OTCQX, Growth, Environment, NYSE, PINK, Renin, Renting, Security (finance), Music, Cryptocurrency, Video game, Financial services

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the second quarter of 2023.

Key Points: 
  • BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the second quarter of 2023.
  • “As we have previously disclosed, our portfolio companies are facing challenges associated with inflationary pressures, rising interest rates, and global economic uncertainty, and our operating results for the second quarter reflect these challenges.
  • The following selected information relates to the financial results of the Company’s principal holdings: BBX Capital Real Estate, BBX Sweet Holdings, and Renin.
  • Further, Renin does not expect to be in compliance with its covenants in future periods as a result of its actual and expected operating results for 2023.

BBX Capital, Inc. Reports Financial Results For the First Quarter of 2023

Retrieved on: 
Wednesday, May 10, 2023
Residential Building & Real Estate, Lodging, Commercial Building & Real Estate, Construction & Property, Vacation, REIT, Travel, Professional Services, Food, Beverage, Retail, Finance, Altman, BBX, Faneuil Hall, TD, Bank statement, BBX Capital Corporation, Tax, BVH, Toronto-Dominion Bank, Balance sheet, Sale, Acquisition, Investment, OTCQX, Growth, NYSE, PINK, Renin, Renting, Security (finance), Cryptocurrency, Video game, Film industry, Reinsurance, Snack

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the first quarter of 2023.

Key Points: 
  • BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the first quarter of 2023.
  • “During the first quarter of 2023, BBX Capital Real Estate (‘BBXRE’) acquired the remaining equity interests in the Altman Companies, and the Company consolidated both the Altman Companies and various real estate joint ventures sponsored by the Altman Companies in its financial statements.
  • The following selected information relates to the financial results of the Company’s principal holdings: BBX Capital Real Estate, BBX Sweet Holdings, and Renin.
  • As of March 31, 2023, Renin was in compliance with the financial covenants under its credit facility with TD Bank.

BBX Capital, Inc. Reports Financial Results For the Fourth Quarter and Full Year of 2022

Retrieved on: 
Wednesday, March 15, 2023
Residential Building & Real Estate, Lodging, Commercial Building & Real Estate, Construction & Property, Vacation, REIT, Travel, Interior Design, Food, Beverage, Retail, Home Goods, OTCQX, Sale, PINK, Absorption, NYSE, Depreciation, Balance sheet, BBX Capital Corporation, Investment, Times Square, Growth, Tax, Total, Michigan Avenue, BBX, BVH, Cryptocurrency, Generic drug, Holding company, Financial adviser, Renting, Video game, Insurance, Financial services, Reinsurance, Health care, Renin

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the fourth quarter and year ended December 31, 2022.

Key Points: 
  • BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the fourth quarter and year ended December 31, 2022.
  • “Overall, we are pleased with BBX Capital's results for the year ended December 31, 2022.
  • We also expect BBX Capital Real Estate to be dramatically impacted in 2023 by an anticipated decrease in sales transactions and new development starts.
  • The following selected information relates to the financial results of the Company’s principal holdings: BBX Capital Real Estate, BBX Sweet Holdings, and Renin.

BBX Capital Real Estate and The Altman Companies Close on Land and Financing to Commence Development of Altra Kendall in Miami, Florida

Retrieved on: 
Tuesday, November 29, 2022
Commercial Building & Real Estate, Construction & Property, Finance, Professional Services, Urban Planning, REIT, Interior Design, Residential Building & Real Estate, Housing, BBX, Club, Multimedia, Risk, PETS, Acquisition, OTCQX, Coffee, The Club, PINK, Yoga, Sale, Renin, Altmann, BBX Capital Corporation, BankAtlantic, Investment, Security (finance), Commercial property

About BBX Capital Real Estate: BBX Capital Real Estate, a principal holding of BBX Capital, Inc., is engaged in the acquisition, development, construction, ownership, financing, and management of real estate and investments in real estate joint ventures, including investments in multifamily rental apartment communities, single-family master-planned for sale housing communities, and commercial properties located primarily in Florida.

Key Points: 
  • About BBX Capital Real Estate: BBX Capital Real Estate, a principal holding of BBX Capital, Inc., is engaged in the acquisition, development, construction, ownership, financing, and management of real estate and investments in real estate joint ventures, including investments in multifamily rental apartment communities, single-family master-planned for sale housing communities, and commercial properties located primarily in Florida.
  • BBX Capital Real Estate also manages the legacy assets acquired in connection with BBX Capital, Inc.s sale of BankAtlantic in 2012, including portfolios of loans receivable, real estate properties, and judgments against past borrowers.
  • About The Altman Companies: The Altman Companies, a joint venture between BBX Capital Real Estate and Joel Altman, is engaged in the development, construction, and management of multifamily apartment communities.
  • About BBX Capital, Inc.: BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) is a Florida-based diversified holding company whose principal holdings include BBX Capital Real Estate, BBX Sweet Holdings, and Renin.

BBX Capital, Inc. Announces Intention to Commence a Cash Tender Offer for its Class A Common Stock

Retrieved on: 
Monday, November 21, 2022
Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Personal Information Agent, Renin, Common stock, PINK, Letter, Security (finance), Annual report, BBX Capital Corporation, OTCQX, Compte rendu, Cryptocurrency

The terms and conditions of the tender offer will be described in an offer to purchase and related letter of transmittal that will be mailed to the Companys shareholders shortly after commencement of the tender offer.

Key Points: 
  • The terms and conditions of the tender offer will be described in an offer to purchase and related letter of transmittal that will be mailed to the Companys shareholders shortly after commencement of the tender offer.
  • The tender offer will be subject to certain conditions described in the offer to purchase.
  • None of the Company or its Board of Directors, the Information Agent for the tender offer, or the Depositary for the tender offer will make any recommendation to shareholders as to whether to tender or refrain from tendering their shares in the tender offer.
  • If the tender offer is commenced, the Company will also file a Tender Offer Statement on Schedule TO (the Tender Offer Statement) with the Securities and Exchange Commission (the SEC), which will include as exhibits, among other things, the offer to purchase, letter of transmittal, and related tender offer materials.

CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions

Retrieved on: 
Monday, November 7, 2022
GLOBE, DBP, American College of Cardiology, Plasma, Renin, Death, Adult, M.D, U.S. Securities and Exchange Commission, AHA, CKD, Risk, American College, Plasma protein binding, Hypertension, Population, Conference call, Degenerative disease, SEC, Annual report, Cardiology, ID, Safety, Achievement, Time, Aldosterone, Hyponatremia, Conference, Patient, Urine, American Heart Association, Primary aldosteronism, Kidney, Hypotension, Potassium, Blood pressure, Kidney disease, SBP, Security (finance), COVID-19, Stroke, Phosphorus, Pharmaceutical industry, Collection

WALTHAM, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) announced the presentation today of Phase 2 data from its BrigHtn trial as part of the late-breaking science session at the 2022 American Heart Association (AHA) Scientific Sessions. Baxdrostat is a highly selective, once daily oral small molecule inhibitor of aldosterone synthase.

Key Points: 
  • Baxdrostat significantly decreases aldosterone in plasma and urine, while increasing plasma renin as a physiological compensatory change.
  • These changes in aldosterone and renin following treatment with baxdrostat reflect less salt exposure to the kidney and reduced blood pressure over time.
  • And, unlike earlier generations of aldosterone synthase inhibitors, serum cortisol levels were not reduced, once again confirming the highly selective mechanism of baxdrostat.
  • Though often asymptomatic, hypertension significantly increases the risk of heart disease, stroke, and kidney disease, amongst other diseases.

CinCor Pharma Announces Publication in the New England Journal of Medicine of Phase 2 BrigHtn Data on Selective Aldosterone Synthase Inhibitor Baxdrostat in Treatment-Resistant Hypertension

Retrieved on: 
Monday, November 7, 2022
GLOBE, American College of Cardiology, Renin, Death, Adult, M.D, U.S. Securities and Exchange Commission, The New England Journal of Medicine, CKD, Risk, American College, Plasma protein binding, Hypertension, Population, Degenerative disease, SEC, Annual report, Cardiology, Safety, Achievement, Time, Aldosterone, Patient, Primary aldosteronism, American Heart Association, Security (finance), Blood pressure, Kidney disease, COVID-19, Stroke, Pharmaceutical industry, Medicine, Collection

WALTHAM, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) announced that detailed results from the Phase 2 BrigHtn trial evaluating the safety and efficacy of baxdrostat in treatment-resistant hypertension were published online today in the New England Journal of Medicine. Baxdrostat is a highly selective, once daily oral small molecule inhibitor of aldosterone synthase.

Key Points: 
  • Baxdrostat is a highly selective, once daily oral small molecule inhibitor of aldosterone synthase.
  • The clinical biomarker activity of aldosterone and renin provide mechanistic insight into how baxdrostat achieves selective blood pressure lowering effects with no impact on cortisol.
  • CinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases.
  • Its lead asset, baxdrostat (CIN-107), a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.

BBX Capital, Inc. to Issue Financial Results for the Third Quarter of 2022 on November 9, 2022

Retrieved on: 
Wednesday, November 2, 2022
Commercial Building & Real Estate, Construction & Property, Lodging, Destinations, Travel, Vacation, REIT, Residential Building & Real Estate, PINK, BBX Capital Corporation, OTCQX, Renin, Company, Financial services

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (the Company) announced today that the Company plans to announce its financial results for the quarter ended September 30, 2022, in a press release to be issued after market close on Wednesday, November 9, 2022.

Key Points: 
  • BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (the Company) announced today that the Company plans to announce its financial results for the quarter ended September 30, 2022, in a press release to be issued after market close on Wednesday, November 9, 2022.
  • About BBX Capital, Inc.: BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) is a Florida-based diversified holding company whose principal holdings include BBX Capital Real Estate, BBX Sweet Holdings, and Renin.
  • For additional information, please visit www.BBXCapital.com .
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20221102006033/en/